Targeting ROR2 homooligomerization disrupts ROR2-dependent signaling and suppresses stem-like cell properties of human breast adenocarcinoma

Feng Leng(National Cancer Institute), Suping Zhang(Fujian Medical University)
iScience
December 13, 2024
Cited by 2


Related Papers